Last updated: 2026-10-02 21:39:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
SeaStar Medical Holding Corporation (ICU) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $4,73, with a market capitalisation of $17,36M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2,07 to $7,35. This page covers its latest market performance, valuation, price trends and company information.
$17,36M | |
$3,78 | |
$3 050,00 | |
$2,07 | |
$3,75 | |
507,52K | |
61,97K | |
-- | |
$7,35 | |
$2,07 | |
-- | |
-- |
SeaStar Medical Holding Corporation (ICU) is trading at $4,67 in after-hours trading as of 2026-10-02 21:26:00, up 24,56% ($0,92) from the regular-session close of $3,75.
After-hours trading shows how investors are pricing ICU after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, SeaStar Medical Holding Corporation (ICU) moved from $3,53 to $4,73, representing a gain of 33,94% ($1,20).
The stock traded between $3,22 and $4,77 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 45,25 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 50,3%
ICU is currently trading at $4,73, placing it 50,3% of the way from its 52-week low of $2,07 to its 52-week high of $7,35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 17 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of SeaStar Medical Holding Corporation (ICU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.